FDA, NIH Asked To Explain Their Enforcement of Trial Reporting Requirements

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

FDA, NIH Asked To Explain Their Enforcement of Trial Reporting Requirements

J.W. Schomisch

January 29, 2023 at 12:26 PM EST

Rep. Frank Pallone, D-N.J., the ranking member of the House Energy and Commerce Committee, wants the FDA and National Institutes of Health (NIH) to be more diligent in getting clinical trial sponsors to report trial results on ClinicalTrials.gov. Pallone sent a Jan. 19 letter to the agencies expressing concern “about the lack of compliance by medical product sponsors with req... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

FDA, NIH Asked To Explain Their Enforcement of Trial Reporting Requirements

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT